{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:31:50Z","timestamp":1768563110212,"version":"3.49.0"},"reference-count":23,"publisher":"American Psychiatric Association Publishing","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[1998,9,1]]},"DOI":"10.1176\/ajp.155.9.1189","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T19:56:14Z","timestamp":1418846174000},"page":"1189-1195","source":"Crossref","is-referenced-by-count":98,"title":["Sertraline in the Treatment of Panic Disorder: A Double-Blind Multicenter Trial"],"prefix":"10.1176","volume":"155","author":[{"given":"Robert B.","family":"Pohl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Wolkow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathryn M.","family":"Clary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"R81559CEJBFGHD","doi-asserted-by":"crossref","unstructured":"Roy-Byrne P, Wingerson D, Cowley D, Dager S: Psychopharmacologic treatment of panic, generalized anxiety disorder, and social phobia. Psychiatr Clin North Am 1993; 16:719\u2013735","DOI":"10.1016\/S0193-953X(18)30146-1"},{"key":"R81559CEJBGEAF","unstructured":"Pohl R, Yeragani VK, Balon R, Lycaki H: The jitteriness syndrome in panic disorder patients treated with antidepressants. J Clin Psychiatry 1988; 49:100\u2013104"},{"key":"R81559CEJEBDEG","unstructured":"Noyes R Jr, Garvey MJ, Cook BL, Samuelson L: Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study. J Clin Psychiatry 1989; 50:163\u2013169"},{"key":"R81559CEJDIFFJ","doi-asserted-by":"crossref","unstructured":"Schweizer E, Rickels K, Weiss S, Zavodnick S: Maintenance drug treatment of panic disorder, I: results of a prospective, placebo-controlled comparison of alprazolam and imipramine. Arch Gen Psychiatry 1993; 50:51\u201360","DOI":"10.1001\/archpsyc.1993.01820130053009"},{"key":"R81559CEJDBGBI","unstructured":"Jobson KO, Davidson JR, Lydiard RB, McCann UD, Pollack MH, Rosenbaum JF: Algorithm for the treatment of panic disorder with agoraphobia. Psychopharmacol Bull 1995; 31:483\u2013485"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Hoehn-Saric R, McLeod DR, Hipsley PA: Effect of fluvoxamine on panic disorder. J Clin Psychopharmacol 1993; 13:321\u2013326","DOI":"10.1097\/00004714-199310000-00004"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Black DW, Wesner R, Bowers W, Gabel J: A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993; 50:44\u201350","DOI":"10.1001\/archpsyc.1993.01820130046008"},{"key":"R81559CEJDEEBF","unstructured":"Bakish D, Hooper CL, Filteau MJ, Charbonneau Y, Fraser G, West DL, Thibaudeau C, Raine D: A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia. Psychopharmacol Bull 1996; 32:135\u2013141"},{"key":"R81559CEJBEJBG","doi-asserted-by":"crossref","unstructured":"Oehrberg S, Christiansen PE, Behnke K, Borup AL, Severin B, Soegaard J, Calberg H, Judge R, Ohrstrom JK, Manniche PM: Paroxetine in the treatment of panic disorder: a randomized, double-blind, placebo-controlled study. Br J Psychiatry 1995; 167:374\u2013379","DOI":"10.1192\/bjp.167.3.374"},{"key":"R81559CEJCFBBA","doi-asserted-by":"crossref","unstructured":"Lecrubier Y, Bakker A, Dunbar G, Judge R: A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators. Acta Psychiatr Scand 1997; 95:145\u2013152","DOI":"10.1111\/j.1600-0447.1997.tb00388.x"},{"key":"R81559CEJECFHI","doi-asserted-by":"crossref","unstructured":"Greist J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K: Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry 1995; 52:289\u2013295","DOI":"10.1001\/archpsyc.1995.03950160039008"},{"key":"R81559CEJCEJJH","unstructured":"Gupta MA, Gupta AK: Chronic idiopathic urticaria associated with panic disorder: a syndrome responsive to selective serotonin reuptake inhibitor antidepressants? Cutis 1995; 56:53\u201354"},{"key":"R81559CEJDDAGJ","doi-asserted-by":"crossref","unstructured":"Papp LA, Weiss JR, Greenberg HE, Rifkin A, Scharf SM, Gorman JM, Klein DF: Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders (letter). Am J Psychiatry 1995; 152:1531","DOI":"10.1176\/ajp.152.10.1531a"},{"key":"R81559CEJDBBHA","doi-asserted-by":"crossref","unstructured":"Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50\u201355","DOI":"10.1111\/j.2044-8341.1959.tb00467.x"},{"key":"R81559CEJBFABH","doi-asserted-by":"crossref","unstructured":"Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278\u2013296","DOI":"10.1111\/j.2044-8260.1967.tb00530.x"},{"key":"R81559CEJEAIBG","doi-asserted-by":"crossref","unstructured":"Endicott J, Nee J, Harrison W, Blumenthal R: Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993; 29:321\u2013326","DOI":"10.1037\/t49981-000"},{"key":"R81559CEJBCCHA","doi-asserted-by":"crossref","unstructured":"Shear MK, Maser JD: Standardized assessment for panic disorder research: a conference report. Arch Gen Psychiatry 1994; 51:346\u2013354","DOI":"10.1001\/archpsyc.1994.03950050006001"},{"key":"R81559CEJCJCAB","doi-asserted-by":"crossref","unstructured":"Ballenger JC, Burrows GD, DuPont RL Jr, Lesser IM, Noyes R Jr, Pecknold JC, Rifkin A, Swinson RP: Alprazolam in panic disorder and agoraphobia: results from a multicenter trial, I: efficacy in short-term treatment. Arch Gen Psychiatry 1988; 45:413\u2013422","DOI":"10.1001\/archpsyc.1988.01800290027004"},{"key":"atypb3","doi-asserted-by":"crossref","unstructured":"Lydiard RB, Lesser IM, Ballenger JC, Rubin RT, Laraia M, DuPont R: A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder. J Clin Psychopharmacol 1992; 12:96\u2013103","DOI":"10.1097\/00004714-199204000-00004"},{"key":"R81559CEJCHICJ","doi-asserted-by":"crossref","unstructured":"Schweizer E, Patterson W, Rickels K, Rosenthal M: Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder. Am J Psychiatry 1993; 150:1210\u20131215","DOI":"10.1176\/ajp.150.8.1210"},{"key":"R81559CEJDFFDH","doi-asserted-by":"crossref","unstructured":"Pollack MH, Otto MW, Tesar GE, Cohen LS, Meltzer-Brody S, Rosenbaum JF: Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. J Clin Psychopharmacol 1993; 13:257\u2013263","DOI":"10.1097\/00004714-199308000-00005"},{"key":"R81559CEJBHCIE","doi-asserted-by":"crossref","unstructured":"Keller MB, Hanks DL: Course and outcome in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 1993; 17:551\u2013570","DOI":"10.1016\/0278-5846(93)90005-D"},{"key":"R81559CEJDABBJ","doi-asserted-by":"crossref","unstructured":"Gorman JM, Liebowitz MR, Fyer AJ, Goetz D, Campeas RB, Fyer MR, Davies SO, Klein DF: An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol 1987; 7:329\u2013332","DOI":"10.1097\/00004714-198710000-00007"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.155.9.1189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T21:44:18Z","timestamp":1722375858000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.155.9.1189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9,1]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1998,9,1]]}},"alternative-id":["10.1176\/ajp.155.9.1189"],"URL":"https:\/\/doi.org\/10.1176\/ajp.155.9.1189","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9,1]]}}}